These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 21087567)

  • 1. Rare problems associated with the Fontan circulation.
    Goldberg DJ; Dodds K; Rychik J
    Cardiol Young; 2010 Dec; 20 Suppl 3():113-9. PubMed ID: 21087567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The failing Fontan: etiology, diagnosis and management.
    Goldberg DJ; Shaddy RE; Ravishankar C; Rychik J
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):785-93. PubMed ID: 21714609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-Losing Enteropathy and Plastic Bronchitis After the Fontan Operation.
    Peyton C
    Crit Care Nurse; 2018 Dec; 38(6):e5-e12. PubMed ID: 30504504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-losing enteropathy and the Fontan operation.
    Johnson JN; Driscoll DJ; O'Leary PW
    Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis.
    Rychik J; Goldberg D; Rand E; Semeao E; Russo P; Dori Y; Dodds K
    Cardiol Young; 2013 Dec; 23(6):831-40. PubMed ID: 24401255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fontan-associated protein-losing enteropathy and plastic bronchitis.
    Schumacher KR; Stringer KA; Donohue JE; Yu S; Shaver A; Caruthers RL; Zikmund-Fisher BJ; Fifer C; Goldberg C; Russell MW
    J Pediatr; 2015 Apr; 166(4):970-7. PubMed ID: 25661406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lymphatic Circulation in Adaptations to the Fontan Circulation.
    Menon S; Chennapragada M; Ugaki S; Sholler GF; Ayer J; Winlaw DS
    Pediatr Cardiol; 2017 Jun; 38(5):886-892. PubMed ID: 28210768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forty years of the Fontan operation: a failed strategy.
    Rychik J
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2010; 13(1):96-100. PubMed ID: 20307870
    [No Abstract]   [Full Text] [Related]  

  • 9. The Fontan procedure: anatomy, complications, and manifestations of failure.
    Fredenburg TB; Johnson TR; Cohen MD
    Radiographics; 2011; 31(2):453-63. PubMed ID: 21415190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts: development of a survivorship programme for patients with a functionally univentricular heart.
    Goldberg DJ; Dodds K; Rychik J
    Cardiol Young; 2011 Dec; 21 Suppl 2():77-9. PubMed ID: 22152532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fontan operation and the single ventricle.
    AboulHosn JA; Shavelle DM; Castellon Y; Criley JM; Plunkett M; Pelikan P; Dinh H; Child JS
    Congenit Heart Dis; 2007; 2(1):2-11. PubMed ID: 18377510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Treatment Options for the Failing Fontan Circulation.
    Driesen BW; Voskuil M; Grotenhuis HB
    Curr Cardiol Rev; 2022; 18(4):e060122200067. PubMed ID: 34994331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-losing enteropathy after Fontan operation: resolution after baffle fenestration.
    Jacobs ML; Rychik J; Byrum CJ; Norwood WI
    Ann Thorac Surg; 1996 Jan; 61(1):206-8. PubMed ID: 8561554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of the fontan circulation.
    Gewillig M; Goldberg DJ
    Heart Fail Clin; 2014 Jan; 10(1):105-16. PubMed ID: 24275298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone.
    Grattan MJ; McCrindle BW
    Congenit Heart Dis; 2010; 5(2):165-7. PubMed ID: 20412490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-losing enteropathy resolved by percutaneous intervention.
    Butera G; Marini D; MacDonald ST
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):584-8. PubMed ID: 21805565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure.
    Cheung EW; Chay GW; Ma ES; Cheung YF
    Am J Cardiol; 2005 Dec; 96(11):1571-5. PubMed ID: 16310443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
    Ostrow AM; Freeze H; Rychik J
    Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fontan procedure: old lessons and new frontiers.
    Setty SP; Herrington CS
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):515-21. PubMed ID: 16918270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver disease in the patient with Fontan circulation.
    Wu FM; Ukomadu C; Odze RD; Valente AM; Mayer JE; Earing MG
    Congenit Heart Dis; 2011; 6(3):190-201. PubMed ID: 21443554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.